Literature DB >> 18300194

A norsesquiterpene lactone and a benzoic acid derivative from the leaves of Cyclocarya paliurus and their glucosidase and glycogen phosphorylase inhibiting activities.

Jun Li1, Yuanyuan Lu, Xiaojian Su, Fu Li, Zhigang She, Xingcun He, Yongcheng Lin.   

Abstract

Two novel compounds, 3-methoxypterolactone ( 1) and 2-amino-3,4-dihydroxy-5-methoxybenzoic acid ( 2), were isolated from leaves of Cyclocarya paliurus (Batal.) Iljinsk, together with nine known compounds: pterolactone ( 3), gallic acid ( 4), 4-hydroxy-3-methoxybenzoic acid ( 5), oleanolic acid ( 6), beta-boswellic acid ( 7), alpha-boswellic acid ( 8), beta-amyrin ( 9), beta-amyrone ( 10) and 3beta-O-trans-caffeoyl-morolic acid ( 11). The structure elucidation was based on spectroscopic methods, including two-dimensional NMR experiments ( (1)H- (1)H COSY, HMQC and HMBC). All isolated compounds were evaluated for their glycosidase and glycogen phosphorylase inhibitory activities. 2-Amino-3,4-dihydroxy-5-methoxybenzoic acid and gallic acid showed significant alpha-glucosidase and glycogen phosphorylase inhibitory activities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300194     DOI: 10.1055/s-2008-1034309

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  3 in total

1.  Bioactive Evaluation of Ursane-Type Pentacyclic Triterpenoids: β-Boswellic Acid Interferes with the Glycosylation and Transport of Intercellular Adhesion Molecule-1 in Human Lung Adenocarcinoma A549 Cells.

Authors:  Kaori Nakano; Saki Sasaki; Takao Kataoka
Journal:  Molecules       Date:  2022-05-11       Impact factor: 4.927

2.  Purification of a water extract of Chinese sweet tea plant (Rubus suavissimus S. Lee) by alcohol precipitation.

Authors:  Gar Yee Koh; Guixin Chou; Zhijun Liu
Journal:  J Agric Food Chem       Date:  2009-06-10       Impact factor: 5.279

3.  Identification of Digestive Enzyme Inhibitors from Ludwigia octovalvis (Jacq.) P.H.Raven.

Authors:  Dulce Morales; Guillermo Ramirez; Armando Herrera-Arellano; Jaime Tortoriello; Miguel Zavala; Alejandro Zamilpa
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-16       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.